Franklin O. Smith, III, MD
Title
Director, Hematology / Oncology
Fellowship Program Director, Hematology / Oncology
Appointment
Professor of Pediatrics; Marjory J. Johnson Endowed Chair
Email
frank.smith@cchmc.org
Phone
513-636-8811
Fax
513-636-3549
Credentials
BS: Chemistry, Wofford College, Spartanburg, South Carolina, Cum Laude, 1980
MD: University of South Carolina School of Medicine, Columbia, South Carolina, 1984
Internship and Residency: University of Florida, College of Medicine, Department of Pediatrics, Gainesville, Florida, 1984 - 1987
Fellowship: Pediatric Hematology / Oncology, University of Washington and the Fred Hutchinson Cancer Research Center, Seattle, Washington, 1987-1990
Certification: National Board of Medical Examiners, Diplomate, 1985; American Board of Pediatrics, 1988, 1999; American Board of Pediatrics, Pediatric Hematology / Oncology, 1992, 1998
Position History
Marjory J. Johnson Endowed Chair in Pediatric Hematology/Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, 2001-Present
Professor of Pediatrics, with Tenure, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, 2001-Present
Director, Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2001-Present
Director, Fellowship Training Program, Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, 2008-Present
Professor of Pediatrics, Medicine, Microbiology & Immunology, with Tenure, Indiana University School of Medicine, Indianapolis, Indiana, 2000-2001
Investigator, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, April 2000-2001
Biography
Dr. Frank Smith received his MD from the University of South Carolina School of Medicine and completed post-doctoral training in pediatrics at the University of Florida and a fellowship training in pediatric hematology / oncology at the University of Washington and the Fred Hutchinson Cancer Research Center.
Dr. Smith is a specialist in the field of acute myeloid leukemia and cord blood transplantation. He has had numerous articles published in prestigious medical and scientific journals nationally and internationally.
Dr. Smith is active with various international and national committees and societies in the field of research and clinical care.
Awards and Honors
- Impact Volunteer of the Year, Leukemia and Lymphoma Society, Southern Ohio Chapter, 2008
- Best Doctors in America, 2008
- American Pediatric Society, 2005
- Alpha Omega Alpha, Alumni Inductee, University South Carolina School of Medicine, Beta Chapter, 2005
- Alpha Omega Alpha, South Carolina Beta Chapter, 2005
- Distinguished School of Medicine Physician Alumni Award, University of South Carolina, 2005
- American Pediatric Society, 2005
- Young Alumnus Of The Year Award, Wofford College, 1999
- American Society of Clinical Oncology Young Investigator Award, 1991
- Leukemia Society of America Fellow, 1991-1994
- Hadley Award for Excellence in Pediatric Research, University of Florida, 1985
- Pediatric Resident of the Year, University of Florida, 1985
National/International Leadership
National Institutes of Health, PDQ Pediatric Cancer Treatment Advisory Board, 2002-Present
Foundation for the Accreditation of Cell Therapy (FACT), Board of Directors, Treasurer, 2002-Present
National Marrow Donor Program, Histocompatibility Committee, Member, 2002-Present
American Society of Clinical Oncology, Pediatric Cancer Track Program Committee, 2004-Present
American Society of Hematology and US Food and Drug Administration, Clinical Endpoints in Acute Leukemias Workshop, Chair, Pediatric Acute Myelogenous Leukemia, 2004-2005
Children's Oncology Group, Chair, Myeloid Disease Committee, 2002-Present
Children’s Oncology Group, Vice Chair-elect, 2006-2007
Children’s Oncology Group, Vice Chair, 2007-Present
Research
Acute myeloid leukemia; cord blood transplantation; gene therapy
Research Grants and Contracts
U01 CA097452 (Adamson) 01/03 – 12/08 NIH/NCI
Children's Oncology Group Phase I/Pilot Consortium
U10 CA98543 (Reaman) 03/01/03-02/28/13 National Childhood Cancer Foundation/National Cancer Institute
Children’s Oncology Group, Co-Investigator
R01 FD002612-01 9/30/05-5/31/08 Food and Drug Administration
Oxandrolone for the Treatment of Marrow Aplasia in Fanconi Anemia, Principal Investigator
Publications, Most Recent
Connect to Frank Smith's publications of PubMed
Manuscripts (2004-present)
Lange BJ, Smith FO, Feusner J, Barnard D, Dinndorf P, Feig S, Heerema NA, Arndt C, Arceci RJ, Seibel N, Weiman M. “Outcomes in CCG-2961, A Children’s Oncology Group Phase 3 Trial for Untreated Pediatric Acute Myeloid Leukemia (AML): A Report from the Children’s Oncology Group.” Blood 111(3): 1044-53, 2008.
Aplenc R, Alonzo TA, Gerbing RB, Lange B, Hurwitz C, Wells RJ, Winter L, Bernstein I, Buckley P, Krimmel K, Grover S, Smith FO, Sievers E, Arceci RJ. “Safety and Efficacy of Gemtuzumab Ozogamicin in Combination with Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children’s Oncology Group (COG).”Journal of Clinical Oncology 26(14):2390-3295, 2008.
Elder DA, D’Alessio DA, Eyal O, Mueller R, Smith FO, Kansra AR, Rose SR. “Abnormalities in Glucose Tolerance are Common in Children with Fanconi Anemia and Associated with Impaired Insulin Secretion.”Pediatric Blood and Cancer 2008.
Aplenc R, Alonzo TA, Gerbing RB, Lange B, Hurwitz C, Wells RJ, Winter L, Bernstein I, Buckley P, Krimmel K, Grover S, Smith FO, Sievers E, Arceci RJ. "Safety and Efficacy of Gemtuzumab Ozogamicin in Combination with Chemotherapy for Pediatric Acute Myeloid Leukemia." Accepted, Journal of Clinical Oncology.
Lange BJ, Smith FO, Feusner J, Barnard D, Dinndorf P, Feig S, Heerema NA, Arndt C, Arceci RJ, Seibel N, Weiman M. "Outcomes in CCG-2961, A Children's Oncology Group Phase 3 Trial for Untreated Pediatric Acute Myeloid Leukemia (AML): A Report from the Children's Oncology Group." Accepted, Blood.
Morrison MR, Spector LG, Blair CK, Robison LL, Olshan AF, Smith FO, Ross JA. "Maternal Diet and Risk of Acute Leukemia in Children with Down Syndrome: A Children's Oncology Group Study." Cancer Causes Control, In Press.
Puumala SE, Ross JA, Olshan AF, Robison LL, Smith FO, Spector LG. "Reproductive History, Infertility Treatment, and the Risk of Acute Leukemia in Children with Down Syndrome: A Report from the Children's Oncology Group (COG)." Cancer 110 (9): 2067-2074, 2007
Sherafat-Kazemzadeh R, Mehta SN, Care NM, Kim MO, Williams DA, Rose SR; and the Fanconi Anemia Comprehensive Care Center: Breech L, Callen M, Davies S, Gluckman J, Groh E, Harris R, Heist S, Hillard P, Hopkins R, Kelly P, Kiefhaber T, Leslie N, Mehlman C, Meyer R, Minevich E, Mueller R, Rose SR, Rutter M, Schmid C, Smith F, Strife F. "Small Pituitary Size in Children with Fanconi Anemia." Pediatric Blood and Cancer 49(2): 166-70, 2007.
Farzin A, Davies SM, Smith FO, Filipovich AH, Hansen M, Auerbach AD, Harris RE. "Matched Sibling Donor Haematopoietic Stem Cell Transplantation in Fanconi Anemia: An Update of the Cincinnati Children's Experience." British Journal of Haematology 136: 633-640, 2007.
Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO, Wilmot F, McCarthy PL, Hahn T. "The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review." Biol Blood Marrow Transplantation 13: 500-501, 2007.
Kelly PF, Radtke S, Kalle C, Balcik B, Bohn K, Mueller R, Schuesler T, Haren M, Reeves L, Cancelas JA, Leemhuis T, Harris R, Auerbach AD, Smith FO, Davies SM, Williams DA. "Stem Cell Collection and Gene Transfer in Fanconi Anemia." Mol Ther 15: 211-9, 2007.
Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO. "Minimally Differentiated Acute Myeloid Leukemia (FAB AML-M0) is Associated with an Adverse Outcome in Children: A Report From the Children's Cancer Group Studies CCG-2891 and -2961." Blood, 109 (6): 2314-2321, 2007.
Appelbaum FR, Rosenblum D, Arceci RJ, Carroll W, Breitfeld PP, Forman SJ, Larson RA, Lee SJ, Murphy SB, O'Brien S, Pazdur R, Radich J, Scher NS, Smith FO. "Endpoints to Establish the Efficacy of New Agents in the Treatment of Acute Leukemia." Blood, 109 (5): 1810-1816, 2007.
Linabery AM, Olshan AF, Gamis AS, Smith FO, Heerema NA, Blair CK, Ross JA. "Exposure to Medical Test Irradiation and Acute Leukemia Among Children with Down syndrome: A Report from the Children's Oncology Group." Pediatrics, 118(5): e1499-508, 2006.
Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA, McGlennen R, Smith FO, Woods WG, Salzer WL, Johnstone HS, Dreyer Z, Reaman GH. "CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors. A Report From the Children's Oncology Group." Blood, 108(2): 441-451, 2006.
Aplenc R, Alonzo TA, Gerbing RB, Smith FO, Meshinchi S, Ross JA, Perentesis J, Woods WG, Lange BJ, Davies SM. "Ethnicity and Survival in Childhood Acute Myeloid Leukemia: A Report from the Children's Oncology Group." Blood, 108(1): 74-80, 2006.
Smith FO, Alonzo TA, Gerbing RB, Woods WG, Arceci RJ. "Long-term Results of Children with Acute Myeloid Leukemia: A Report of Three Consecutive Phase III Trials by the Children's Oncology Group: CCG 251, CCG 213 and CCG 2891." Leukemia 19: 2054-2062, 2005.
Radeva J, Van Scoyoc E, Smith FO, Curtis L, Breitfeld PP. "National Estimate of Use of Hematopoietic Stem Cell Transplantation in Children with Cancer."Bone Marrow Transplantation, 36: 397-404, 2005.
Ross JA, Blair CK, Olshan AF, Robison LL, Smith FO, Heerema NA, Roesler M. "Periconceptional vitamin use and leukemia risk in children with Down syndrome: A Children's Oncology Group Study." Cancer, 104: 405-410, 2005.
Arceci RJ, Sande J, Lange B, Shannon F, Franklin J, Hutchinson R, Vik T, Flowers D, Leopold L, Sherman ML, Smith FO, Bernstein I, Sievers EL. "Safety and Efficacy of Gemtuzumab Ozogamicin (Mylotarg") in Pediatric Patients with Advanced CD33-Positive Acute Myeloid Leukemia."Blood, 106: 1183-1188, 2005.
Alonzo TA, Wells RJ, Woods WG, Lange B, Gerbing RB, Neudorf S, Sanders J, Smith FO, Feig SA. "Postremission Therapy for Children with Acute Myeloid Leukemia. The Children's Cancer Group Experience in the Transplant Era."Leukemia, 19: 965-970, 2005.
Lange BJ, Gerbing RB, Feusner J, Skolnik J, Sacks N, Smith FO, Alonzo TA. "Excess Mortality in Morbidity Obese and Underweight Pediatric Patients with Acute Myeloid Leukemia."Journal of American Medical Association, 293: 203-211, 2005.
Canfield KN, Spector LG, Robison LL, Lazovich DeAnn, Roesler M, Oshan AF, Smith FO, Heerema NA, Barnard D, Blair CK, Ross JA. "Childhood and Maternal Infections and Risk of Acute Myeloid Leukemia in Children with Down Syndrome: A Report from the Children's Oncology Group."British Journal of Cancer, Pre-published Nov 2, 2004.
Lange BJ, Dinndorf P, Smith FO, Arndt C, Barnard D, Feig S, Feusner J, Seibel N , Weiman M, Aplenc R, Gerbing R, Alonzo TA. "Pilot Study of Idarubicin-Based Intensive-Timing Induction Therpay for Children with Previously Untreated Acute Myeloid Leukemia: Children's Cancer Group Study 2941,"Journal of Clinical Oncology, 22: 150-156, 2004.
Invited Papers, Lectures and Presentations (2005-present)
Invited Speaker, "The Challenges and Rewards of Investigator Initiated Trials", Translational Research Trials Office of Sponsored Symposium, Cincinnati, 2008.
Invited Speaker, "Cincinnati Children’s Hospital Medical Center: Estate Planning Strategies for Low Interest Rates 'Drug Development and Pediatric Cancer'", Cincinnati, Ohio, May 15, 2008.
Invited Professor, "Fanconi Anemia: A Model For Translational Research", Baylor University, Texas Children's Hospital, Houston, TX, 2007
Invited Professor, "Pediatric Myeloid Leukemia: Past, Present and Future", Grand Rounds, University of Montreal, Hospital Sainte-Justine, Montreal, Canada, 2007
Invited Professor, "Fanconi Anemia: A Model for Translational Research", McGill University Health Center and L'Hopital de Montreal Pour Enfants, Montreal, Canada, September 2007
Invited Professor, "Pediatric Myeloid Leukemia: Past, Present and Future", Division of Hematology, Centre Universitaire de Sante McGill, McGill University Health Center and Montreal General Hospital, Montreal, Canada, September 2007
Invited Speaker, Foundation for the Accreditation of Cellular Therapy Inspector Training and Preparing Your Center for Inspection Workshop, Keystone, CO, 2007
Sponsor, Organized, Chair and Session Chair, Stem Transplantation in Children, Meeting #9, San Diego, California, 2007.
Visiting Professor, University of New Mexico Health Sciences Center and School of
Medicine, "Fanconi Anemia: A Model Disease From Bench to Bed Therapy," Albuquerque, New Mexico, 2006.
Invited Speaker, Fanconi Anemia Research Foundation Family Meeting, "Approaches to Bone Marrow Failure" Camp Sunshine, Maine 2006.
Invited Speaker, National Marrow Donor Program, "Pediatric Acute Myeloid Leukemia: Advances, Evidence, and the Future," Minnneapolis, Minnesota, 2006.
Invited Speaker, 7th Annual Pediatric and Neonatal Hematology/Oncology for the Practitioner, University School of New Mexico Health Sciences Center and School of Medicine, "Bone Marrow Failure Syndromes," Albuquerque, New Mexico, 2005.
Invited Speaker, Fanconi Anemia Research Foundation Family Meeting, "Bone Marrow Transplantation in Fanconi Anemia Patients," Camp Sunshine, Maine 2005.
Invited Speaker, FACT Clinical Standards, Section B, Foundation for the Accreditation of Cellular Therapy Inspector Training and Preparing Your Center For Inspection Workshops, International Society for Cellular Therapy, Vancouver, British Columbia, Canada, 2005.
Invited Speaker, Grant Seminar Series, "K Awards," Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2005.
Invited Speaker, Provider Performance Improvement: Up Close and Personal, "Division of Hematology/Oncology: Physician Performace Based Measurments," First Annual Medical Staff Conference on Provider-Specific Performance, Cincinnati, Ohio, 2005.
Invited Speaker, Principle Investigator/Research Coordinator Symposium, "Overview of Clinical Trials," 28th Annual Meeting of the National Sickle Cell Disease Programs, Cincinnati, Ohio, 2005.
Co-Organizer, Third Annual Midwest Blood Club Symposium, Louisville, Kentucky, 2005.
Co-Sponsor, Organizing Committee and Session Chair, Stem Transplantation in Children, Meeting 8, Scottsdale, Arizona, 2005.
Invited Speaker, Clinical Research Associate's Education Session, "Current Approaches to AML Therapy", Children's Oncology Group Meeting, Atlanta, Georgia, 2004
Invited Speaker, Cancer Free Kids Gala, "Childhood Caner," Cincinnati, Ohio 2004.
Invited Speaker, Nursing Continuing Education, Cincinnati Children's Hospital Medicla Center, "Gene Therapy for Fanconi Anemia," Cincinnati, Ohio 2004.
Invited Speaker, Fanconi Anemia Research Foundation Family Meeting, "Gene Therapy," Camp Sunshine, Maine 2004.
Keynote Speaker, Leukemia and Lymphoma Society, Maui King's Trail Triathlon, Wailea, Maui, June 12, 2004.
Invited Speaker, Cincinnati Children's Hospital Medical Center, Past, Present, and Future of Pediatric Oncology Nursing Symposium, "Clinical Trials," Cincinnati, Ohio, ay 25, 2004.
Invited Speaker, Cincinnati Children's Hospital Medical Center, Past, Present, and Future of Pediatric Oncology Nursing Symposium, "Overview for Pediatric Oncology," Cincinnati, Ohio, May 25, 2004.
Keynote Speaker, Cincinnati Children's Hospital Medical Center: Hematology/Oncology Nursing Open House, "Stem Cell Transplantation," Cincinnati, Ohio May 19, 2004.
Abstracts (2004-present)
Presented Abstracts
Dreyer ZE, Dinndorf P, Sather H, Hilden JM, Devidas M, Heerema NA, Smith FO, Carroll W, Reaman G, Camitta BM. “Hematopoietic Stem Cell Transplant (HSCT) Versus Intensive Chemotherapy in Infant Acute Lymphoblastic Leukemia (ALL).” Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 9514
Smith FO, Kelly P, Harris R, Rose SR, Ris, Kim M-O, Radtke S, Arnold V, Wilson K, Williams, DA. “A Majority of Patients with Fanconi Anemia Respond to Low Dose Androgens: A Pilot Trial of Oxandrolone.” Nineteenth Annual Fanconi Anemia Research Fund Scientific Symposium, Chicago, IL, 2007.
Champagne MA, Fu C, Chang M, Cooley L, Heerema NA, Wood C, French ME, Smith FO, Bernstein ML. “Imatinib in Children with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CP CML): AAML0123 COG Study.” Blood 108: 2140a, 2006.
Sharma M, Alonzo TA, Sorrell A, Doyle RJ, Bayer L, Perentesis JP, Ross J, Smith FO, Byrnes R, Husong J, Hathaway L, Gamis A. “Uniform Approach Better Defines Natural History of Transient Myeloproliferative Disorder (TMD) in Down Syndrome (DS) Neonates: Outcomes from Children’s Onoclogy Group (COG) Study A2971.” Blood 108: 376a, 2006.
Gamis AS, Alonzo TA, Hilden JM, Gerbing RB, Loew TW, Hathaway L, McGarvran L, Barnard D, Taub JW, Ravindranath Y, Smith FO, Arceci R. “Outcome of Down Syndrome (DS) Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Treated with a Uniform Prospective Clinical Trial-Initial Report of the COG Trial A2971.” Blood 108: 376a, 2006.
Harris RE, Smolarek TA, Monzon S, Smith FO, Davies S, Williams DA. “Retrospective Cytogenetic and FISH Analyses in Fanconi Anemia Patients Evaluated at Cincinnati Children's Hospital Medical Center.” 17th Annual Fanconi Anemia Research Fund Scientific Symposium, Geneva, Switzerland, 2005.
Kelly PF, Smith FO, Harris R, Kalle C, Davies S, Mueller R, Radtke S, Haren M, Leemhuis T, Reeves L, Jurikova I, Balcik B, Bohn K, Williams DA. “Collection and Purification of Fanconi Anemia CD34+ Hematopoietic Stem Cell and Progenitor Cells (HSC) for Autologous Use: Initial Clinical Results.” 17th Annual Fanconi Anemia Research Fund Scientific Symposium, Geneva, Switzerland, 2005.
Kelly PF, Smith FO, Mueller R, Balick B, Bohn K, Schuesler T, Leemhuis T, Reeves L, Harris R, Radtke S, Haren M, Jurickova I, Davies S, Kalle C, Williams DA. “Gene Transfer for Patients with Fanconi Anemia, Genotype A: A Pilot Study.” 17th Annual Fanconi Anemia Research Fund Scientific Symposium, Geneva, Switzerland, 2005.
Smith FO, Kelly PF, Harris RE, Rose S, Altaye M, Radtke S, Haren M, Williams DA. “A Pilot Trial of Oxandrolone for the Treatment of Bone Marrow Failure for Patients with Fanconi Anemia.” 17th Annual Fanconi Anemia Research Fund Scientific Symposium, Geneva, Switzerland, 2005.
Kelly P, Balcik B, Bohn K, Mueller R, Jurickova I, Schuesler T, Reeves L, Leemhuis T, Harris R, Davies SM, Smith FO, von Kalle C, Williams DA. “Early Results of the Clinical Collection and Genetic Correction of Fanconi Complement Type A Hematopoietic Stem Cells.” Blood 105: 1283a, 2005.
Loew TW, Gamis A, Smith FO, Massey GV, Woods WG, Hilden JM, Lange B, Alonzo TA, Chang M, Gerbing RB. "Induction Therapy Failures in Down Syndrome Patients with Acute Myelogenous Leukemia." Blood 104: 4527a, 2004.
Loew TW, Smith FO, Massey GV, Woods WG, Hilden JM, Lange B, Alonzo TA, Chang M, Gerbing RB. "Down Syndrome Patients with Relapsed Acute Myelogenous Leukemia." Blood 104: 4526a, 2004.
Blackman SC, Palumbo JS, Davies SM, Smith FO, Saal HM. "Investigation Of A Patient With Diamond-Blackfan Anemia and a 3q27 Chromosome Deletion." 5th Annual Diamond Blackfan Anemia International Consensus Conference, New York City, New York, April 2004.
Blackman SC, Davies SM, Smith FO, Harris RE. "Failure of Metoclopramide As Adjunct Therapy in Pediatric Diamond-Blackfan Anemia Patients." 5th Annual Diamond Blackfan Anemia International Consensus Conference, New York City, New York, April 2004.
Blackman SC, Davies SM, Smith FO, Harris RE. "Failure of Metoclopramide as Adjunct Therapy in Pediatric Diamond-Blackfan Anemia Patients." Pediatric Blood and Cancer 42: 1046, 2004.
Lange BJ, Dinndorf P, Smith FO, Arndt C, Barnard DR, Feig SA, Feusner J, Seibel N, Weiman M, Aplenc R, Gerbing R, Alonzo TA. "A Pilot Study of Idarubicin-Based Intensive Timing Induction Therapy for Children with Previously Untreated Acute Myeloid Leukemia in Children's Cancer Group (CCG) Study 2941." Blood 102: 873a, 2003.
Barbaric D, Alonzo TA, Gerbing RB, Barnard DR, Lange BJ, Woods WG, Smith FO. "Is Pediatric Minimally Differentiated Acute Myeloid Leukemia Associated with an Adverse Outcome?" Blood 102: 872a, 2003.
Professional Organization Memberships
- American Academy of Pediatrics, 1991-Present
- American Society of Blood and Marrow Transplantation, 1994-Present
- International Society of Experimental Hematology, 1995-Present
- American Society of Hematology, 1995-Present
- The International Society for Hematotherapy and Graft Engineering, 1996-Present
- American Society of Pediatric Hematology/Oncology, 1997-Present
- American Society of Clinical Oncology, 1997-Present
- Society of Regenerative Medicine and Stem Cell Biology, 2001-Present
- American Academy of Pediatrics, Section of Hematology-Oncology, 2001-Present
- American Society of Gene Therapy, 2001-Present
Books
Chapters (2004-present)
Rubnitz JE, Gibson B, Smith FO. "Acute Myeloid Leukemia." In Pediatric Clinics of North America. Editor. 2008 Feb 55(1):21-51.
Broxmeyer HE and Smith FO. "Cord Blood Hematopoietic Cell Transplantation." In Hematopoietic Cell Transplantation. Editors: Blume, Forman, and Applebaum. Fourth Edition. In Press.
Smith FO and Loh ML. "Myelodysplastic and Myeloproliferative Syndromes in Children." in Hematology: Basic Principles and Practice. Editors: Hoffman, Benz, Hattil, Fuire, Silberstein, McGlave and Heslop. Fifth Edition. In Press.
Smith FO and Woods WG. "Myeloproliferative and Myelodysplastic Disorders." in Principles and Practice of Pediatric Oncology. Editors: Pizzo and Poplack. Fifth Edition. 673-694, 2005.
Kaiser S, Smith FO, Aronow BJ. "Oncogenomics: Progress Towards Personalized Molecular Diagnosis and Therapies for Cancer." In Cancer Therapy: Molecular Targets in Tumor-Host Interactions. Editor; Weber GF. Horizon Bioscience. 13-25, 2005.
Broxmeyer HE and Smith FO. "Cord Blood Hematopoietic Cell Transplantation." In Hematopoietic Cell Transplantation. Editor; Blume, Forman, and Appelbaum. Third Edition, 550-564, 2004.
Smith FO, Srour EF, Broxmeyer HE. "Ex Vivo Expansion and Gene Transduction of Cord Blood Stem Cells." In Cellular Characteristics of Cord Blood and Cord Blood Transplantation. Editor, Broxmeyer HE. American Association Blood Banking. Second Edition, 125-150, 2004.
Smith FO. "Immune Reconstitution Following Umbilical Cord Blood Transplantation." In Cellular Characteristics of Cord Blood and Cord Blood Transplantation. Editor, Broxmeyer HE. American Association Blood Banking. Second Edition, 151-162, 2004.
Special Interests
Acute myeloid leukemia; cord blood transplantation; gene therapy
Editorial Board and Review Experience
Reviewer
- Bone Marrow Transplantation
- Journal of Pediatrics
- Cancer
- American Journal of Pediatric Hematology / Oncology
- Journal of Pediatric Surgery
- European Journal of Haematology
- American Journal of Hematology
- Journal of Pediatric Surgery
- Journal of Leukocyte Biology
- Journal of Pediatric Hematology / Oncology
- Pediatric Blood and Cancer
- Leukemia - The Journal of Normal and Malignant Hemopoiesis
- Biology of Blood and Marrow Transplantation
Editorial Board
- Cancer Research Therapy and Control, Section Editor, Transplantation Biology, 1997-2001
- British Journal of Haematology, Editorial Board, 2006-Present
- Journal of Hematotherapy and Stem Cell Research, Editorial Board, 2000-2007
- Blood, Editorial Board, 2002-2007
- Medscape General Medicine, Topics in Pediatric Leukemia, Editor, 2004-Present
Related Areas
This person works in these other areas at Cincinnati Children's Hospital Medical Center:
